Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.690

+0.1%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (764)	1/14/2008 3:45:44 PM
From: Jibacoa	Read Replies (1) of 802

It seems INGN may retest its recent support at the $2.60 level, as investors keep waiting for news on the BLA, MAA & EMEA on Advexin.<g> The stock is down 4.2% with volume still below its ADV. bigcharts.marketwatch.com The short ratio came down 27% in the last month, but is still > 39x its ADV.<g> Insiders reportedly hold >20% & institutions > 10% finance.yahoo.com If there aren't any other adverse news, it seems the stock won't go below the $2 level this time around.<g> I will continue to watch it & may add to my position when the shorts start covering a little more.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next